I wonder if at the heart of it, this is a political issue and has anything to do with the
Orphan Drug laws. Before these laws were in place, drugs were often not developed for conditions that occurred relatively low in the population, due to low profitability for the drug companies. As I understand it, under the Orphan Drug laws, these companies are now eligible for incentives to develop drugs which might not otherwise be developed.